Citation tools
"64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy." Journal of Nuclear Medicine
60.6
(2019):
777-785.
Web. 19 April. 2024.